Venlafaxine in the Treatment of Postpartum Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: Although postpartum depression is a highly prevalent illness, antidepressant treatment studies of postpartum depression are sparse. Incomplete recognition and treatment of puerperal illness place women at risk for chronic depression and may have adverse effects on child development. METHOD: An 8-week, flexible-dose, open study of venlafaxine (immediate release; mean dose = 162.5 mg/day) was performed in a group of 15 women who met DSM-III-R criteria for major depressive disorder with onset within the first 3 months postpartum. Patients were assessed at baseline and every 2 weeks across the study. Measurements of outcome included the 17-item Hamilton Rating Scale for Depression (HAM-D), the Kellner Symptom Questionnaire, and the Clinical Global Impressions scale (CGI). RESULTS: Despite baseline scores of depression that were particularly high, response to treatment was robust. Twelve of 15 patients experienced remission of major depression (HAM-D score < or = 7 or CGI score < or = 2). Dramatic decrease in anxiety paralleled the decrease in depression across the sample. CONCLUSION: Venlafaxine is effective in the treatment of postpartum major depression. Early identification of women who suffer from postpartum mood disturbance is critical to minimize the morbidity associated with untreated mood disturbance and the effect of depression on children and families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressants can effectively decrease PPD symptoms (e.g., Cohen et al. 2001; Wisner et al. 2002; Yonkers et al. 2008)”
From Perinatal Dyadic Psychotherapy for postpartum depression: a randomized controlled pilot trial (2015) · cites this paper as Cohen et al. 2001
Citations
Cited by
Items 101–122 of 122
Altieri, M. A., da Silva, A. S., Moreira, S. D. S., Zapaterini, J. R., Arena, A. C., & Barbisan, L. F. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108451 · Cited by 1
Treatment-resistant depression in pregnancy, the postpartum period, and transition to menopause
Kaufman, Y., Eichenbaum, R. M., Carlini, S. V., & Deligiannidis, K. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00037-2 · Cited by 1
Psychiatric Conditions During Peripartum and Perimenopause
Payne, J. L., & Kornstein, S. G. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch118 · Cited by 1
The relationship between sleep quality, physical activity and postpartum mood
Nash, C. O., & Kloss, J. D. (2014) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-6373 · Cited by 4
Postpartale Depression — Darauf sollten Gynäkologlnnen achten
Bitzer, J., & Alder, J. (2006) · Springer eBooks · doi:10.1007/3-211-29956-4_5 · Cited by 1
Carter, A. J. (2010) · Summit (Simon Fraser University)
The development, treatment, and prevention of perinatal mood and anxiety disorders
Sockol, L. E. (2013) · Scholarly Commons (University of Pennsylvania)
Psychiatric disorders of menses, pregnancy, postpartum and menopause
Buist, A., Yonkers, K. A., & Craig, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.020
Novel Uses of Selective Serotonin Reuptake Inhibitors in Women
El‐Ibiary, S. Y., & Lee, K. C. (2003) · Journal of Pharmacy Practice · doi:10.1177/0897190003016003007
“In addition to active treatment of PPD, antidepressants, hormonal therapy, and psychosocial therapies have been shown to be potentially useful in the prevention of recurrent PPD.”
BackgroundInfluentialA review of human immunodeficiency virus (HIV) and postpartum depression
Owusu, K. A., Patel, R., & Chung, A. M. (2013) · Mental Health Clinician · doi:10.9740/mhc.n140593
POST-PARTUM DEPRESSION- TREATMENT UPDATE
Choudhary, V., Hatila, S., & Mehta, S. (2020) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v4i1.843
Postpartum Depression: Making the Case for Routine Screening
Keshen, A. R., & MacDonald, J. L. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v7i1.529
“" Administration of TCAs or SSRIs is not contraindicated during breastfeeding.”
BackgroundInfluentialThe Effects of Maternal Antidepressant Usage on a Child’s Psychological Health
Pearse, S. O. (2021) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
(2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.356
Psychiatric Illness during Pregnancy and the Postpartum Period
Wang, B. H., Freeman, M. P., Nonacs, R. M., Viguera, A. C., & Cohen, L. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-1927-7.00046-7
Self-citationUse of Antidepressants in Nursing Mothers
(2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0788-5.10048-3
Alternative Treatments for Postpartum Depression
Thomson, M., & Sharma, V. (2023) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-023-00295-5 · Cited by 1
“Serotonin-noradrenergic reuptake inhibitors (SNRIs) [24] and bupropion [25] have also been supported through open-label studies [26, 27].”
BackgroundPsychiatric Conditions During Peripartum and Perimenopause
Payne, J. L., & Kornstein, S. G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_4-1 · Cited by 1
Benjamin, C., Atalay, R. T., Kolawole, O., Ramallo, M., McAllister, V., Akinyemi, O. A., Siraga, M., & Michael, M. B. (2024) · Cureus · doi:10.7759/cureus.55208
“…sertraline, paroxetine, venlafaxine, fluoxetine, nefazodone, and nortriptyline, and several open trials have found that a variety of antidepressants are associated with symptomatic improvement over eight to 12 weeks of treatment, the controlled trials have yielded more equivocal results [13,15].”
ResultPsychiatric Conditions During Peripartum and Perimenopause
Payne, J. L., & Kornstein, S. G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_4
Pharmacotherapy of postpartum depression: An update
Kumar, K., Pallavi, K., Martand, K., & Maharshi, V. (2025) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2025.001 · Cited by 1
Muzik, M., Marcus, S. M., Heringhausen, J. E., & Flynn, H. A. (2009) · Clínicas obstétricas y ginecológicas de Norteamérica
Metadata
- Authors
- Cohen, L. S., Viguera, A. C., Bouffard, S. M., Nonacs, R. M., Morabito, C., Collins, M. H., & Ablon, J. S.
- Affiliations
- Harvard University (US)
- ORCID
- Viguera, Adele C.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-08-15
- Volume
- 62
- Issue
- 8
- Pages
- 592-596
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1982259960
- Cited by
- 122
- References
- 0
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 9 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 8 · 2012: 2
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- venlafaxine, postpartum depression, antidepressant treatment, major depressive disorder, puerperal depression, treatment response, remission, anxiety reduction, maternal mental health, child development
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Anxiety Disorders, Cyclohexanols, Depressive Disorder, Drug Administration Schedule, Female, Humans, Psychiatric Status Rating Scales, Severity of Illness Index, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Depression, Postpartum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.